PLRZ · Polyrizon Ltd
United States · RS rating 70 · As of 2026-11-03
| Price | 11.40 USD |
|---|---|
| 1-day change | +1.3% |
| RS rating (overall / 1M / 3M / 12M) | 70 / 95 / 70 / 92 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 29 / 25 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +33.6% |
| Market cap (USD) | $26.4M |